| 1. | eTruth | |
| 2. | user74399 | |
| 3. | parispenelope21 |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | user74399 03/14/2018 someone knew this |
| 2. | user74399 01/10/2019 La Jolla (LJPC) Stock Crashes -- Is There a Light at the End of the Tunnel? |
| 3. | user74399 03/07/2018 GIAPREZA™ (angiotensin II) Significantly Improved Survival and Reduced Time on Renal Replacement Therapy in Patients with Acute Kidney Injury |
| 4. | parispenelope21 03/22/2018 Announces that GIAPREZA (angiotensin II), injection for intravenous infusion, is now commercially available … |
| 5. | eTruth 08/09/2018 dang it, already bought a long time ago |
| 6. | eTruth 02/22/2018 ER |
| 7. | user74399 03/14/2018 La Jolla Pharmaceutical Company Announces $100 Million Public Offering of Common Stock |
| 8. | eTruth 03/14/2018 Announces $100 mln public offering of common stock |
| 9. | eTruth 02/21/2018 La Jolla Pharmaceutical Company Announces the Treatment of First Patient in GIAPREZA™ (angiotensin II) Pediatric Study |
| 10. | eTruth 02/26/2018 GIAPREZA™ (angiotensin II) Significantly Improved Survival of Patients with High APACHE II Scores in ATHOS-3 Study |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
La Jolla Pharmaceutical Company
- LJPC
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.